SCHEMBL4710792

SCHEMBL4710792

COc1cccc(/C=C/c2cccc(C)n2)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.63
NPC1 O15118 2/20 0.63
MEN1 O00255 2/20 0.63
KMT2A Q03164 2/20 0.63
GRM5 P41594 1/20 0.63
RAB9A P51151 1/20 0.63
GRM4 Q14833 1/20 0.63
SMN1; SMN2 Q16637 1/20 0.63
NPSR1 Q6W5P4 1/20 0.63
HDAC6 Q9UBN7 1/20 0.63
KDM4E B2RXH2 1/20 0.63
CYP3A4 P08684 1/20 0.63
CYP2D6 P10635 1/20 0.63
CYP2C9 P11712 1/20 0.63
PKM P14618 1/20 0.63
HPGD P15428 1/20 0.63
TSHR P16473 1/20 0.63
NFKB1 P19838 1/20 0.63
CYP2C19 P33261 1/20 0.63
THPO P40225 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4710793 1.00 ALDH1A1 (0.63) ALDH1A1NPC1MEN1KMT2AGRM5
SCHEMBL4713452 0.89 NPC1 (0.60) ALDH1A1NPC1MEN1KMT2AGRM5
SCHEMBL4713450 0.89 NPC1 (0.60) ALDH1A1NPC1MEN1KMT2AGRM5
SCHEMBL4711274 0.85 GRM4 (0.69) ALDH1A1NPC1MEN1KMT2AGRM5
SCHEMBL4711271 0.85 GRM4 (0.69) ALDH1A1NPC1MEN1KMT2AGRM5
SCHEMBL4536867 0.83 MEN1 (0.58) NPC1MEN1KMT2AHSP90AA1ECE2
SCHEMBL4536873 0.83 MEN1 (0.58) NPC1MEN1KMT2AHSP90AA1ECE2
SCHEMBL4712966 0.81 KMT2A (0.55) ALDH1A1NPC1MEN1KMT2AGRM5
SCHEMBL4712968 0.81 KMT2A (0.55) ALDH1A1NPC1MEN1KMT2AGRM5
SCHEMBL23158820 0.81 RELA (0.84) RELANFE2L2CYP1A1CYP1A2CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0998459-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2008-04-23 EP claimed
EP-0998459-A2 PYRIDINE DERIVATIVES Novartis AG (CH) 2000-05-10 EP claimed
WO-1999002497-A2 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 1999-01-21 WO claimed
EP-0998459-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2008-04-23 EP disclosed
US-6656957-B1 Marked and selective modulating, especially antagonistic, action at human metabotropic glutamate receptors (mGluRs); treatment of disorders such as epilepsy, cerebral ischemias, especially acute ischemias, spasticity etc. NOVARTIS AG (CH) 2003-12-02 US disclosed